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Abstract
The Aβ peptide aggregates into amyloid plaques at presymptomatic stages of Alzheimer's disease,
but the temporal relationship between plaque formation and neuronal dysfunction is poorly
understood. Here, we demonstrate that the connectivity of the peripheral olfactory neural circuit is
perturbed in mice overexpressing human APPsw (Swedish mutation) prior to the onset of plaques.
Expression of hAPPsw exclusively in olfactory sensory neurons (OSNs) also perturbs connectivity
with associated reductions in odor-evoked gene expression and olfactory acuity. By contrast, OSN
axons project correctly in mice overexpressing wild type human APP throughout the brain and in
mice overexpressing human APPmv, a missense mutation that reduces Aβ production, exclusively
in OSNs. Furthermore, expression of Aβ40 or Aβ42 solely in the olfactory epithelium disrupts
OSN axon targeting. Our data indicate that altering the structural connectivity and function of
highly plastic neural circuits is one of the pleiotropic actions of soluble human Aβ.
The pathobiology of Alzheimer's disease (AD) erodes neural networks and their underlying
neural circuits, resulting in cognitive deficits and, ultimately, dementia1. Accumulations of
Aβ peptide assemblies in the cortex, especially amyloid plaques, are present years prior to
the onset of clinical symptoms of AD2. In fact, approximately thirty percent of cognitively
intact septuagenarians harbor cerebral amyloid plaques3, 4. Defining the temporal
relationship between neural network dysfunction and amyloid deposition is crucial to
developing effective therapies for the preclinical stage of AD5.
Transgenic mice overexpressing pathogenic mutated alleles of the human amyloid precursor
protein (APP) model the cerebral amyloidosis of preclinical AD6. In these models, neurons
surrounding amyloid plaques exhibit reduced dendritic spine density and elevated resting
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tintracellular calcium concentrations7, 8. However, loss of synaptic proteins precede amyloid
deposition in these models9, and soluble Aβ species disrupt neural network function, e.g,
inhibiting long-term potentiation, inducing long-term depression (LTD), and diminishing the
density of dendritic spines10, 11. Lentiviral expression of hAPP, but not hAPPmv (M671V, a
synthetic missense mutation of hAPP which impairs Aβ generation12), in hippocampal slice
preparations evoked a LTD-like phenotype and reduced spine density in adjacent neurons
not expressing hAPP13-15. Together, these data indicate that soluble Aβ species, either
released from cells or diffusing from the periphery of amyloid deposits, mediate neural
circuit dysfunction.
In this study we probe the actions of human Aβ in the mouse peripheral olfactory neural
circuit in vivo, a genetically tractable established model of neuronal connectivity.
Interestingly, the neural network underpinning olfactory perception and odor naming is
compromised early in AD16. Each mouse olfactory sensory neuron (OSN) expresses a single
olfactory receptor (OR), choosing from over one thousand OR genes17. Each OR gene can
be modified to express marker proteins or disease genes in a defined OSN cell type with
exquisite specificity. To a first approximation, this circuit is organized as over 1000 parallel
channels defined by OR proteins, which govern the response properties to odors18 and the
sites of axon projection on the surface of the olfactory bulb19, 20. Collectively, these OR-
dictated projection loci form a stereotyped map. We find that overexpression of the Swedish
mutation of human APP (hAPPsw), which causes early onset AD21, disrupts the
connectivity of OSNs, reduces activity-dependent gene expression in second-order olfactory
neurons, and compromises olfactory acuity. These findings are not present in control mouse
lines that overexpress wild type hAPP or M671V human APP (hAPPmv). Moreover,
expression of Aβ40 or Aβ42 restricted to the olfactory epithelium also disturbs OSN axon
targeting. These results indicate that human Aβ induces axon dysfunction in vivo in the
absence of amyloid plaques.
Results
OSN Axons Mistarget in Mice Overexpressing hAPPsw
Axons of OSNs expressing the same OR innervate discrete glomeruli on the surface of the
olfactory bulb (Fig. 1a). The naturally occurring hAPPsw (K670N, M671L) augments
cleavage by the β-secretase thereby increasing Aβ production (Fig. 1b)22. We bred Tg2576
mice22, which overexpress hAPPsw throughout the brain, including OSNs in the olfactory
epithelium (Supplementary Figure S1) with a mouse line in which the P2 OR gene was
modified to also express GFP20. In control animals, a single glomerulus predominantly
received fluorescent fibers in each bulb hemisphere. (Fig. 1c – d). By contrast, in littermate
animals overexpressing hAPPsw, P2 axon projections terminate within multiple glomeruli
per half bulb (Fig. 1e – f).
To confirm this phenotype, we examined a distinct subpopulation of OSNs expressing a
different olfactory receptor, MOR28. In control mice, axons labeled with an antibody
against MOR2823 projected to only one glomerulus per half bulb (Fig. 1g – h). However, in
Tg2576 mice multiple adjacent glomeruli per half olfactory bulb received MOR28-labelled
fibers (Fig. 1i – j). This phenotype was observed in both males and females, and at ages
ranging from 10 days to 12 months. Thus, mistargeting of axons in the olfactory system
occurs before plaque deposition in the olfactory bulbs of Tg2576 mice (Fig. 1k – n).
Intact Targeting in Mice Overexpressing Wild type Human APP
In I5 mice overexpressing the wild type human APP gene (hAPPwt)9, immunostaining of
the olfactory epithelium revealed robust expression of hAPPwt in OSNs (Figure 2a – b). We
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tbred the I5 mouse line with a line in which the P2 OR gene was modified to also express the
fusion protein mouse tau-β-galactoside (tauLacZ)20. Immunostaining of the olfactory bulb
using an anti-LacZ antibody did not reveal differences in targeting of axons of OSNs
expressing P2 (Fig. 2c – d). Similiarly, the fidelity of targeting of axons of OSNs expressing
MOR28 was also preserved (Fig. 2e – f) relative to littermate controls. These preserved axon
projection patterns suggest that overexpression of the hAPPsw allele alters connectivity of
this neural circuit.
Selective Expression of hAPPsw in OSNs Alters Connectivity
To determine whether expression of hAPPsw exclusively in OSNs was sufficient to cause
OSN axon mistargeting, we generated transgenic mouse lines that coexpress hAPPsw and
the axonal marker human placental alkaline phosphatase (PLAP) in a conditional manner
using the tetracycline transcriptional activator (TTA)/TetO system24. These transgenic lines
were crossed with a mouse line where the olfactory marker protein (OMP) gene was
modified to coexpress TTA (Fig. 3a)25. Immunohistochemical analysis of the olfactory
epithelium of compound heterozygote mice demonstrated that a subset of the OSNs express
hAPPsw (Fig. 3b – c). Immunostaining of the olfactory bulb indicated that OSNs expressing
PLAP project broadly to the glomeruli of the olfactory bulb (Fig. 3d – e). Overall,
approximately 12% (319/2653) of OSNs expressed the transgene products hAPPsw and
PLAP, except in the very lateral region where the expression was markedly reduced, 1.4%
(28/2017). The proportion of expression in the M71-defined subpopulation was 18.4% (28
hAPP+/152 OSNs), but the expression of hAPPsw in the lateral OSNs expressing MOR28
was 0.19% (5 hAPP+/2604 OSNs). Importantly, we do not observe a shift in the pattern of
expression of ORs over the olfactory epithelium. This mouse line expressing hAPPsw and
PLAP was termed CORMAP (Conditional, Olfactory Sensory Neuron Restricted Mosaic
expression of APPsw and PLAP).
Immunostaining of CORMAP mice bearing a modified P2 gene also expressing the tau-
LacZ fusion protein20 revealed multiple glomeruli receiving fibers labeled with LacZ, which
was significantly different from immunostaining littermate P2/tau-LacZ mice expressing
only the TTA transcription factor alone (Fig. 3f – h; p < 0.001; two-tailed t test; n = 15
(control); n = 18 (CORMAP)). Similarly, crossing CORMAP mice with a mouse line with a
modified M71 gene also expressing the tau-LacZ fusion protein26 revealed multiple
glomeruli receiving LacZ fibers per half bulb (Fig. 3i – k; p < 0.04; two tailed t test; n = 17
(control); n = 12 (CORMAP)). OSNs expressing MOR28 predominantly targeted one
glomerulus per half bulb in CORMAP mice and control littermates (Fig. 3l – n); the intact
targeting likely reflects the scant transgene expression in that region of the epithelium.
Overall the axon guidance phenotypes were similar to those observed in Tg2576, indicating
that restricted expression of hAPPsw to OSNs is sufficient to disrupt their axon targeting.
Selective Expression of hAPPmv in OSNs Maintains Connectivity
Since hAPPsw facilitates production of Aβ, we generated transgenic mouse lines that
coexpresses M671V human APP (hAPPmv) (Fig. 1b), a hAPP isoform that impairs Aβ
production12, and the axonal marker mCherry in a conditional manner as described above
(Fig. 4a). Similarly, a subset of medial OSNs (17.6%; 239/1366) expressed hAPPmv and
mCherry (Fig. 4b – c), and smaller subset of lateral OSNs (4.7%; 37/782) expressed the
transgene. OSNs expressing mCherry projected broadly to the glomeruli in the olfactory
bulb (Fig. 4d – e). The proportion of transgene expression in the MOR28-defined
subpopulation mirrored the ambient density of the lateral epithelium (4.6%; 26 hAPP+/568
OSNs). Moreover, we did not observe a shift in the pattern of expression of ORs over the
olfactory epithelium. This mouse line expressing hAPPmv and mcherry was termed
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tCORMAC (Conditional, Olfactory Sensory Neuron Restricted Mosaic expression of APPmv
and mCherry).
The number of glomeruli targeted by OSNs coexpressing P2 and tau-LacZ in CORMAC
mice was similar to control littermates (Fig. 4f – h). Similarly, the distribution of targeted
glomeruli by M71-expressing OSNs did not differ between CORMAC mice and control
littermates (Fig. 4i – k). Moreover, predominantly one glomerulus per half bulb was labeled
with an antibody against MOR28 in both hAPPmv and control littermates (Fig. 4l – n). In
summary, the patterns of connectivity of OSNs in CORMAC mice were preserved, thus,
demonstrating the specificity of the hAPPsw phenotype.
A mouse line overexpressing a synthetic APP isoform (mouse/human chimeric protein with
Swedish and Indiana mutations) was recently reported to generate high levels of human Aβ,
which in turn caused accelerated OSN death27. In our study, levels of activated caspase 3
and the density of OSN subpopulations in Tg2576, CORMAP, or CORMAC lines were not
significantly different from control littermates (Supplementary Fig. S2).
Olfactory Deficits Correlate with Altered Connectivity
The OSN-specific restricted expression of hAPP isoforms in both CORMAP and CORMAC
lines affords the opportunity to determine the functional consequence of these connectivity
deficits using odor-evoked behavioral assays without the potential confounds that central
neural circuits may be affected by hAPP expression. We assessed olfactory function in these
lines using two paradigms. The response to 2,3,5-trimethyl-3-thiazoline (TMT), an odorant
isolated from fox feces with an innate aversive response to mice, was monitored (Fig. 5a)28.
CORMAP, but not CORMAC, mice spent significantly more time within region of the arena
where TMT was present (Fig. 5b – c). Moreover, in an olfactory assay monitoring appetitive
behavior 29, food restricted CORMAP mice took significantly more time to find food buried
under mouse bedding relative to littermate controls (Fig. 5d – e). Together, these olfactory
assays indicate that compromised olfactory function correlates with alterations in structural
connectivity of the peripheral olfactory neural circuit.
Reduced Expression of Activity-Dependent Gene Products
To confirm that the functional responses of OSNs was compromised in the CORMAP line,
we quantified tyrosine hydroxylase (TH) expression by periglomerular dopaminergic
neurons as a surrogate marker of OSN input activity30. Statistically significant reductions in
levels of the TH signal were measured in the glomerular layer of CORMAP mice relative to
wild type littermates (Fig. 6a – c; p < 0.01; two-tailed t test; n = 5 mice per genotype) that
had been housed in the same cage. In addition, we quantified the expression of the
immediate early gene Arc in periglomerular and tufted neurons of CORMAP mice relative
to littermate controls. We observe a significant reduction in the number of neurons
expressing Arc (Fig. 6d – f; p < 0.01; two-tailed t test; n = 60 – 100 per genotype). Since
periglomerular and tufted neurons in the olfactory bulbs of CORMAP mice do not express
hAPPsw, we interpret these reduced levels of TH and Arc as reflecting reduced input from
OSNs.
Expression Aβ40 or Aβ42 Disturbs OSN Axon Targeting
The specificity of the hAPPsw phenotype implies that a BACE1 cleavage product of APP
mediates axon dysfunction of OSNs. To determine whether the expression of human Aβ
disrupts axon targeting of OSNs, we transduced the olfactory epithelia of mice with AAV
expressing either the Bri-Aβ40 fusion protein or the Bri-Aβ42 fusion protein, which are
cleaved sequentially by furin to secrete the human Aβ40 or Aβ42 peptide, respectively31.
We instilled one naris of M71/tauLacZ mice with AAV8 expressing either Bri-Aβ40 or Bri-
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tAβ42. The uninfected side served as a control. After 12 weeks, examination of M71-
expressing OSNs revealed disturbed axon targeting on the infected side compared with the
non-infected side (Fig. 7a – c). In control experiments, infection of AAV8 expressing GFP
in one naris did not disturb M71 axon targeting (data not shown). Immunostaining of the
olfactory epithelia from infected mice using the anti- human APP and Aβ antibody 6E10
revealed expression in the superficial layers of the olfactory epithelium. The cells expressing
human Aβ40 costained with a marker for non-neuronal sustentacular cells (Supplementary
Fig. S3a – d). Similarly, the infected side with Bri-Aβ42 expressing virus also caused axon
mistargeting of M71-expressing axons (Fig. 7d – f). Of note, immunostaining of both the
infected olfactory epithelium and the ipsilateral olfactory bulb with 6E10 did not reveal
evidence of amyloid deposition (Supplementary Fig. S3e); moreover, formic acid extraction
of the olfactory bulbs from the Bri-Aβ42 infected mice followed by ELISA did not detect
Aβ42 (data not shown). These data support an extracellular mechanism of action of Aβ (that
is likely to be soluble) to disturb axon targeting of OSNs. We cannot exclude the possibility
that other cleavage products of APP contribute to the hAPPsw phenotype.
DISCUSSION
The increasing awareness of the susceptibility of olfactory acuity in people with prodromal
neurodegenerative disease, relative to other sensory modalities, and our deeper
understanding of the physiology underlying olfactory perception32, 33 have made the
olfactory neural network in animals a more widely used model to investigate mechanisms of
neurodegenerative disease34, 35. The amenability of the mouse peripheral olfactory neural
circuit to genetic, imaging, and behavioral characterization renders it a powerful model
system to elucidate the actions of disease proteins16, 27. One of the unique aspects of this
neural circuit is the continuous renewal of OSNs in adults36, necessitating precise axon
targeting throughout its lifetime to maintain the integrity of the circuit. We exploit this
physiologic structural plasticity to visualize dysfunction caused by the expression of genes
that cause neurologic disease. Here, we report that expression of the Swedish mutation of
human APP in mice in vivo alters the connectivity and function of the peripheral olfactory
neural circuit in the absence of plaques.
Our initial observation of this axon guidance phenotype occurred in well characterized lines
that overexpress hAPPsw throughout the brain. Taking advantage of methodology to
specifically express genes in the peripheral olfactory neural circuit37, we generated and
examined two lines of mice that overexpress human APP alleles exclusively in the
presynaptic neurons of this circuit. Aβ production is facilitated in one line that expresses
hAPPsw and impeded in the other line that expresses hAPPmv12. Overproduction of
hAPPsw in the presynaptic neurons was sufficient to perturb the structural connectivity of
the peripheral olfactory neural circuit. The absence of a phenotype in the hAPPmv line
corroborated our findings in the mouse line overexpressing the wild type form of hAPP.
Together with preserved fidelity of axon targeting in the I5 line overexpressing wild type
hAPP throughout the brain, these important controls indicate that overexpression of human
APP is not sufficient to alter OSN axonal connectivity. Rather, our findings suggest that
products of BACE1-mediated cleavage of APP critically modulate neuronal function — in
congruence with results from studies in hippocampal slices13, 15, 38, in induced human
neurons derived from skin fibroblasts39 and studies of BACE1 heterozygous and null
mice40.
We postulate that Aβ is the BACE1 cleavage product of APP involved in mediating the
connectivity phenotype. The presence of the connectivity phenotype in mice expressing
hAPPsw, but not in the I5 line expressing hAPPwt and not in the CORMAC line expressing
hAPPmv, supports this hypothesis. Moreover, expression of human Aβ40 or human Aβ42 in
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in the projection map of OSN axons. Since we observe these axon targeting deficits in
young mice prior to the onset of plaques in the broadly expressing lines and since we do not
observe amyloid plaques in lines that overexpress hAPP isoforms exclusively in OSNs or in
the virally-infected mice, this novel axonal phenotype is independent of amyloid plaque
deposition. This phenotype is unlikely to be caused by an in utero anomaly since we can
induce it in adult control mice by intranasal expression of Aβ40 or Aβ42. Together, these
data are consistent with a model that soluble Aβ triggers axonal dysfunction in the absence
of amyloid plaques in vivo, although we cannot disprove that insoluble Aβ could also cause
similar changes.
In addition to altering structural connectivity, expression of hAPPsw exclusively in OSNs
has functional consequences as indicated by two lines of evidence. First, relative to control
littermates or CORMAC mice, CORMAP mice exhibit significant reductions in olfactory
acuity in two distinct behavioral paradigms, one paradigm employing an odor that evokes an
aversive response while the other paradigm employs an odor that evokes an appetitive
response. We interpret these olfactory-mediated behavioral responses as reflecting the
function of the peripheral olfactory neural circuit in CORMAP and CORMAC lines — an
interpretation afforded by the restricted expression pattern of hAPPsw and hAPPmv,
respectively. Deficits in an odor habituation paradigm have been reported in Tg2576 mice at
ages 6 - 7 months that correlated with amyloid plaque deposition34. By contrast, the
behavioral phenotype of CORMAP mice is detectable at 3 to 5 months of age and is
independent of amyloid plaques. Secondly, the expression of two independent activity-
dependent markers in postsynaptic neurons in the olfactory bulb were significantly reduced
in CORMAP mice relative to littermate controls. The magnitude of reduction of these
activity-dependent markers (approx. 25%) exceeds the frequency of expression of hAPPsw
in mature OSNs (approx. 12%). This disproportional response in the functional data raises
the possibility that hAPPsw may be acting in a non-cell autonomous manner, as seen in
studies in hippocampal slices by Malinow's laboratory13, 38. Our attempts to determine
whether a non-cell autonomous mechanism underlies the structural connectivity phenotype
in the CORMAP line have not been conclusive to date. Future studies employing expression
of hAPP isoforms by specific OR promotors are aimed to address this question directly.
Our data illustrate a detrimental effect of heightened Aβ levels on a neural circuit in the
absence of plaques. The CORMAP line offers a quantifiable outcome of the actions of
hAPPsw, and likely Aβ, which is distinct from amyloid plaque production and that could be
utilized to assess therapies targeting aberrant neural plasticity due to Aβ. While olfactory
deficits have been shown in patients with prodromal and mild Alzheimer's disease,
demonstration of alterations in the map of OSN projections in the human olfactory bulb in
AD is necessary to postulate that the CORMAP mouse is a model for the disease. Increasing
evidence indicates that Aβ levels rise after neuronal injury by increased expression of APP
and/or BACE141. Established risk factors for late onset AD, e.g. head trauma and vascular
insults, result in elevated Aβ production42. Further delineation of the mechanism of action
of human Aβ in this model system may provide insight into neural circuit and network
dysfunction in the long, preclinical stage of Alzheimer's disease.
Methods
Animals
All experiments were in accordance with protocols approved by the Institutional Animal
Care and Use Committee of Massachusetts General Hospital. Tg2576 mice overexpressing
hAPPsw22 were obtained from Taconic Farms (Hudson, NY). I5 hAPPwt mice9, and M71-
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tires-tauLacZ were obtained from Jackson Labs (Bar Harbor, ME). P2-ires-GFP20 and P2-
ires-tauLacZ43 mice were a gift from Richard Axel.
Generation and Characterization of CORMAP and CORMAC Mice
Transgenic constructs were generated using the hAPPsw695 cDNA, ires-PLAP44 and
pBSRV37 which contained the tetO sequence followed by an artificial intron and splice site,
the Pac site, and an SV40 polyadenylation signal. For the CORMAC mice, the hAPPsw695
(K670N; M671L) cDNA was mutated to the mv genotype (M671V) by PCR mutagenesis
(Stratagene) and confirmed by sequencing. A DNA fragment encoding ires-mcherry was
isolated and the hAPPmv-ires-mcherry fragment was cloned and injected. The founder
mouse was crossed with OMP-ires-tTA mice25. Compound heterozygote mice of the
founders for the CORMAP line expressed hAPPsw and PLAP in approximately 12% of
OSNs and not elsewhere in the brain. This line was backcrossed into C57/BL6 for six
generations. Compound heterozygote mice of a founder for the CORMAC line expressed
hAPPsw and mCherry in approximately 18% of OSNs and not elsewhere in the brain. This
line was backcrossed into C57/BL6 for six generations. The ages of mice used in this study
ranged from 3 weeks to 1 year.
Immunohistochemistry
Standard procedures were used as previously described45. The mice were anesthetized with
an intraperitoneal injection of 3,3,3-tribromoethanol (1.25% in PBS 30 μL/g body weight).
Following thoracotomy, intracardiac perfusion with 10 mL of PBS (pH 7.4) was performed.
For anti-GFP and anti-LacZ immunostaining, the mice were subsequently perfused with 2%
paraformaldehyde in PBS (pH 7.4). The olfactory turbinates and olfactory bulbs were
dissected intact, incubated in 30% sucrose in PBS at 4 °C overnight, and embedded in OCT
(Sakura) or M1 (Shandon) in a dry ice/ethanol bath. Twenty μm coronal sections were cut
on a cryostat (Microm) and collected on SuperFrost slides (Fisher). For immunostaining
using the MOR28 and M71 antibodies, the sections were post-fixed with 1%
paraformaldehyde in PBS for 8 min. at room temperature. All sections were washed three
times in PBS for 10 min., permeabilized in 0.1% Triton X-100 in PBS (PT) for 30 min. at
room temperature, blocked in 5% heat-inactivated horse serum in PT (PTS) for 1 h at room
temperature, incubated with primary antibody in PTS under a Hybrislip (Invitrogen)
overnight in a humidified chamber at 4 °C, washed three times with PT for 10 min, blocked
with PTS for 30 min at room temperature, incubated with a fluorescent-conjugated
secondary antibody in PTS with DAPI (Invitrogen, 1:1000) for 2 h at room temperature,
washed briefly in PBS, and Vectashield was applied to each slide and coverslipped. Slides
were analyzed using a Zeiss LSM-510 confocal microscope or a Leica confocal microscope
and analyzed using ImageJ (NIH).
Primary antibodies included rabbit anti-GFP (Molecular Probes; 1:1000), sheep anti-GFP
(Biogenesis; 1:1000), rabbit anti-LacZ (Cappel; 1;1000), rabbit anti-APP (6900; Zymed;
1;1000), mouse anti-human APP and Aβ (4G8 and 6E10; Covance; 1:1000); rabbit anti-
MOR28 (1:3000) 23 guinea pig anti-M71 (1:1000)23, rabbit anti-activated caspase 3 (Cell
Signaling, 1:500), rabbit anti-TROMA (Molecular Probes; 1:10), and mouse anti-tyrosine
hydroxylase (Millipore; 1:500). Secondary antibodies were Alexa 488-conjugated donkey
anti-rabbit Ig (Molecular Probes; 1:500), Alexa 488-conjugated donkey anti-sheep Ig
(Molecular Probes; 1: 500), Cy3-conjugated donkey anti-guinea pig Ig (Jackson
Immunoresearch; 1: 500), Cy3-conjugated rat anti-mouse Ig (Jackson Immunoresearch;
1:500).
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tIn situ hybridization
Twenty μm thick fresh frozen tissue sections were placed on Superfrost slides (Fisher
Scientific). The sections were dried for 45 minutes at room temperature before fixing with
4% paraformaldehyde for 15 minutes, and washed 3x in 1x DEPC-treated PBS containing
1mM MgCl2. Slides were then immersed in a solution containing 270 mL of DEPC treated
water, 30mL of 1M triethanolamine and 750 μL of 95% acetic anhydride for 10 minutes,
and subsequently washed 3x in 1x DEPC-treated PBS containing 1mM MgCl2. Slides were
then blocked for 2 hours with hyridization buffer: 0.1% Tween20, 50% formamide, 5x SSC,
5x Denhardts, 5mM EDTA, 10mM NaH2PO4 at pH. 8.0, 50mM Tris pH 8.0, 250 μg/mL
salmon sperm DNA, 100 μgram/mL tRNA, 100 μg/mL yeast RNA. Slides were dabbed dry
and Arc antisense RNA probes46 (100 μg/mL), preheated for 5 minutes at 80 degrees and
cooled on ice for 2 minutes, were applied to the slides and sealed in a humidified chamber at
65 overnight. After 18 hrs the slides were washed at 65 degrees C in 3x in 5xSSC for 15
min., and then 3x with 0.2x SSC for 20 min. After blocking in 1x in situ hybridization
blocking solution (Roche) for 1 hour. Slides were dabbed dry and a sheep antibody
recognizing digoxetin (1:3000, Roche) was applied overnight. The next day the RNA probe
was detected using the HNPP fluorescent detection kit (Roche) or BCIP/NBT (Promega).
Whole mount
Whole mount analyses were performed as previously described47. Briefly, mice harboring
the P2-ires-GFP allele were anesthesized as described above. The skull was dissected and
then divided sagittally and the dura was removed from the medial surface of each olfactory
bulb. Each whole mount was placed in PBS with 2 mM MgCl2 and then imaged using a
Leica confocal imaging system. Preparation and staining of olfactory bulbs expressing tau-
LacZ was performed as previously described20.
AAV infection
AAV was introduced intranasally in one naris of 2 month old M71-ires-tauLacZ mice (Bri-
Aβ40) or control mice (Bri-Aβ42) by diluting 2.5 μL of AAV8 virus with 57.5 μL of 2%
methylcellulose in PBS (1% final concentration; 5 × 1012 pfus) as previously described48.
Analysis by immunohistochemistry and whole mount preparation occurred 90 days after
infection.
Behavior
The TMT assay was derived from the curtain assay28. Briefly, the experiment was
performed in the dark during the nocturnal phase of the day. The behavioral arena (Fig. 4a)
was placed in a chemical hood. Mice (age range 3 – 5 m) were habituated to the arena for 3
× 10 min with blank filter papers. After 7 min. of the third habituation, the filter papers were
swapped with identical filter papers with 20 μL of water or TMT, respectively. The
remaining three minutes were videorecorded and scored in a blinded fashion. One-way
analysis of variance and unpaired t-tests were used to analyze the data.
The hidden food assay was derived from similar assays previously described29, 49. The mice
(age ≥ 3 – 9 m) were food restricted for 24 h and then habituated in an 82 cm × 63 cm × 18
cm arena with 2 cm autoclaved mouse bedding for 5 min. Then they are returned to their
home cage for 30 min. Each animal was placed back in the arena with fresh autoclaved
bedding covering 1 g of ground food pellet placed in one specific location. The trial was
analyzed in real time using a stopwatch until the food was ingested. The experimenters
recording the latency to eat the food were blinded to the genotype. The results of between
two experimenters was not significantly different. Each animal was tested once.
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tStatistical Analysis One-way analysis of variance and unpaired t-tests were performed using
SAS, Microsoft Excel, or Apple Numbers and results are presented as mean ± s.e.m.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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tFigure 1. Aberrant OSN projections in transgenic mouse lines overexpressing hAPPsw
(a) Schematic representation of the anatomy of the peripheral olfactory neural circuit
demonstrating that choice of olfactory receptor (OR) (depicted by color) dictates the
projection target of its axon in the olfactory bulb. (b) Schematic representation of the
protease cleavage pathways to generate Aβ and other fragments from hAPP. The mutation
hAPPsw enhances flux through the β-secretase pathway and M671V human APP (hAPPmv)
impairs flux through the β-secretase pathway. (c–d) Representative image of olfactory bulbs
from P2-ires-GFP mice reveal a single glomerulus (indicated by arrow) per half bulb is
targeted by axons containing GFP (each dot represents result per half bulb;). (e–f)
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tRepresentative image and quantification of olfactory bulbs from Tg2576 (panneuronal
hAPPsw)/P2-ires-GFP mice reveal aberrant targeting of fibers containing GFP to multiple
glomeruli (arrows) per half bulb (p < 0.02, two tailed t test; n = 7 (controls); n = 6
(Tg2576)). (g–h) Representative coronal section and quantification of olfactory bulbs from
wild type mice immunostained with anti-MOR28 and TOTO-3 reveal targeting to a single
glomerulus (arrow). (i–j) Representative coronal section and quantification of olfactory
bulbs from Tg2576 hAPPsw mice immunostained with anti-MOR28 and TOTO-3 reveal
aberrant targeting of MOR28 axons to multiple glomeruli (arrows) (p < 0.05, two tailed t
test; n = 8 (controls); n = 11 (Tg2576)). Data presented as means ± s.e.m. (k) The olfactory
bulb from a 13-month old Tg2576 mouse immunostained with 6E10 anti-APP antibody
shows the presence of plaques in the granule cell layer (GR). No plaques are seen in the
glomerular layer (GL). (l–n) The human-specific antibody 4G8 reveals expression of
hAPPsw in the glomerular layer (GL) of Tg2576 (24 months old), but not in wild type mice
(m) or when 4G8 is omitted from the Tg2576 tissue (n). Plaques are seen in granule cell
layer but not in the glomerular cell layers in the 24-month old Tg2576 mouse (l). Scale bar =
100 μm.
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tFigure 2. Preserved OSN projections in transgenic mouse lines overexpressing hAPPwt
(a–b) Olfactory epithelia harvested from 12 week old mice overexpressing the human APP
protein driven by the PDGF β-promotor expressed APP as shown by immunostaining with
anti-APP 6E10 (a) relative to a no primary antibody control (b). Scale bar = 20 μm. (c–d)
Quantification of olfactory bulbs from control one year old P2-ires-GFP mice and from I5
human wild type APP (hAPPwt)-overexpressing mice reveal targeting of fibers containing
GFP to two glomeruli per half bulb in both lines (p > 0.50, two tailed t test; n = 7 (controls);
n = 10 (I5)). (e–f) Quantification of olfactory bulbs from control mice and from I5 hAPPwt
transgenic mice immunostained with anti-MOR28 reveal targeting to a single glomerulus (p
> 0.50, two tailed t test; n = 8 (controls); n = 9 (I5)). Scale bar = 100 μm. Data presented as
means ± s.e.m.
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tFigure 3. Characterization of CORMAP mice
(a) Schematic diagram of the olfactory marker protein (OMP) gene locus altered by
homologous recombination to introduce the internal ribosomal entry sequence (IRES) and
tetracycline transcriptional activator (TTA) (OMP-ivt) and the transgene encoding the
operator sequence TetO followed by hAPPsw, IRES, and PLAP. (b–c) Coronal section of
the medial olfactory epithelium from a control and a CORMAP mouse immunostained with
an anti-APP antibody reveals background expression of the endogenous mouse APP in
OSNs and approximately 12% of OSNs overexpress hAPPsw, respectively. (d–e) Coronal
section of the olfactory bulb of a control and a CORMAP mouse colorimetrically stained for
PLAP activity reveals that PLAP-labelled fibers target glomeruli in a stochastic pattern. (f–
h) Representative images and quantification of olfactory bulbs from P2-ires-tauLacZ (tau-β-
galactosidase fusion protein)/OMP-ivt and P2-ires-tauLacZ/CORMAP mice reveal targeting
of LacZ-bearing neurons to one glomerulus (arrow) in control mice and targeting of LacZ-
bearing axons to multiple glomeruli (arrows) in CORMAP mice (arrows identify glomeruli
revealing P2-expressing fibers) (p < 0.001, two tailed t test; n = 15 (controls); n = 18
(CORMAP)). (i–k) Representative images and quantification of olfactory bulbs from M71-
ires-tauLacZ/OMP-ivt and littermate M71-ires-tauLacZ/CORMAP mice reveal targeting of
LacZ-bearing neurons to one glomerulus in controls and to multiple glomeruli in CORMAP
mice with some fibers crossing between the lateral and medial projection loci. (p < 0.04, two
tailed t test; n = 17 (controls); n = 11 (CORMAP)) (l–n) Representative images and
quantification of olfactory bulbs from control and littermate CORMAP mice stained with
anti-MOR28 antibody reveals MOR28-bearing axons targeting predominantly to a single
glomerulus per half bulb in both lines (p < 0.09, two tailed t test; n = 16 (controls); n = 15
(CORMAP)). Scale bars = 100 μm, except for (i–j) where scale bar = 200 μm. Data
presented as means ± s.e.m.
Cao et al. Page 15
Nat Commun. Author manuscript; available in PMC 2012 December 24.
$
w
a
t
e
r
m
a
r
k
-
t
e
x
t
$
w
a
t
e
r
m
a
r
k
-
t
e
x
t
$
w
a
t
e
r
m
a
r
k
-
t
e
x
tFigure 4. Characterization of CORMAC mice
(a) Schematic diagram of the OMP gene locus altered by homologous recombination to
introduce the IRES and TTA(OMP-ivt) and the transgene encoding the operator sequence
TetO followed by hAPPmv (hAPP M671V), IRES, and the mCherry (CHE). (b–c) Coronal
section of the medial olfactory epithelium from control and CORMAC mice immunostained
with an anti-APP antibody reveals background expression of the endogenous mouse APP in
OSNs and approximately 18% of OSNs overexpress hAPPmv, respectively. (d–e) Coronal
sections of olfactory bulbs from a control mouse and a CORMAC mouse reveal fibers
containing mCherry target glomeruli in a stochastic pattern. (f–h) Representative images and
quantification of olfactory bulbs from P2-ires-tauLacZ/OMP-ivt and P2-ires-tauLacZ/
CORMAC mice reveal targeting of LacZ-bearing neurons to equal glomeruli (arrows) in
both control and CORMAC mice. (p > 0.50, two tailed t test; n = 12 (controls); n = 12
(CORMAC)) (i–k) Representative images and quantification of olfactory bulbs from M71-
ires-tauLacZ/OMP-ivt and littermate M71-ires-tauLacZ/CORMAC mice reveal targeting of
LacZ-bearing neurons to one glomerulus in both control and CORMAC mice. (p > 0.50, two
tailed t test; n = 13 (controls); n = 15 (CORMAC)) (l–n) Representative images and
quantification of olfactory bulbs from MOR28-ires-tauLacZ/OMP-ivt and littermate
MOR28-ires-tauLacZ/CORMAC mice reveal targeting of LacZ-bearing neurons to one
glomerulus (arrow) in both control and CORMAC mice (p > 0.50, two tailed t test; n = 7
(controls); n = 6 (CORMAC)). Scale bars = 100 μm, except for (d-e, i–j) where scale bar =
200 μm.
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tFigure 5. Olfactory behavioral deficit in the CORMAP mice but not CORMAC mice
(a) Schematic representation of the behavioral arena to assess the response to 2,3,5-
trimethyl-3-thiazoline (TMT), an odor isolated from fox feces that triggers an innate
aversion response in mice. (b–c) Percentage of time that each mouse spent in a compartment
with the innately aversive odor TMT relative to a compartment with water for a 3 minute
period. Relative to littermate controls, CORMAC (hAPPmv) but not CORMAP (hAPPsw)
mice avoided TMT. (p < 0.05; one-way ANOVA; n = 5 pairs of littermate mice for each
genotype with ages ranging from 3 to 5 months). (d) Schematic representation of the
behavioral arena to find the buried food. (e) Graphical representation of time to find food for
controls, CORMAC, and CORMAP mice. Relative to controls, CORMAP, but not
CORMAC, required a significantly longer time to find the food (p < 0.04; one-way
ANOVA; n = 4 (control), 3 (CORMAC), and 4 (CORMAP) with ages ranging from 3 to 6
months). Error bars = s.e.m.
Cao et al. Page 17
Nat Commun. Author manuscript; available in PMC 2012 December 24.
$
w
a
t
e
r
m
a
r
k
-
t
e
x
t
$
w
a
t
e
r
m
a
r
k
-
t
e
x
t
$
w
a
t
e
r
m
a
r
k
-
t
e
x
tFigure 6. Reduced induction of OSN activity-dependent genes in CORMAP mice olfactory bulbs
(a) Representative image of olfactory bulbs from a control mouse immunostained with an
antibody recognizing tyrosine hydroxylase (TH) (red) and a nuclear stain (blue). (b)
Representative image of olfactory bulbs from a CORMAP mouse immunostained with an
antibody recognizing TH (red) and a nuclear stain (blue). (c) Quantification of the intensity
of TH staining in glomeruli of CORMAP (n = 5 bulbs) and littermate control mice (n = 5
bulbs) reveals a statistically significant difference (p < 0.01; two-tailed t test). (d)
Representative image of an olfactory bulb from a control mouse following in situ
hybridization with an antisense Arc probe. (e) Representative image of an olfactory bulb
from a CORMAP mouse following in situ hybridization with an antisense Arc probe. (f)
Quantification of number of periglomerular and tufted neurons expressing Arc in matched
regions of the olfactory bulbs from CORMAP (n = 5) and littermate control mice (n = 5)
reveals a significant difference (p < 0.01; two-tailed t test; n = 60 – 100 per genotype). Scale
bar = 100 μm. Error bars = s.e.m.
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tFigure 7. Aβ40 and Aβ42expression in the olfactory epithelium alters OSN axon targeting
(a–b) Representative images of the olfactory bulbs from an M71-ires-tauLacZ mouse
infected with AAV8-BriAβ40 that were stained with X-gal (arrows indicate glomeruli
receiving M71-expressing fibers). Scale bar = 200 μm. (c) Quantification of number of
glomeruli receiving M71 expressing axons revealed a significant degree of mistargeting in
the olfactory bulb ipsilateral to the AAV8-BriAβ40 infection (p < 0.05; two-tailed t test; n =
6 per genotype). (d–e) Representative images of the olfactory bulbs from a mouse infected
with AAV8-BriAβ42 immunostained with antibody that recognizes M71 (arrows identify
glomeruli revealing M71-expressing fibers). Scale bar = 100 μm. (f) Quantification of
number of glomeruli receiving M71 expressing axons revealed a significant degree of
mistargeting in the olfactory bulb ipsilateral to the AAV8-BriAβ42 infection (p < 0.02; two-
tailed t test; n = 5 (controls); n = 6 (AAV8-BriAβ42).
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